United States · FDA National Drug Code directory
NYPOZI txid
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72374-101_23d9f1d4-c25a-45fb-8095-986c659cb532
- Product NDC
- 72374-101
- Form
- INJECTION
- Composition / generic term
- filgrastim-txid
- Labeler
- Tanvex BioPharma USA, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20250923
- Source listing expiry
- 20271231
Source-listed ingredients
- FILGRASTIM — 300 ug/300ug
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE, GLASS in 1 CARTON (72374-101-01) / 300 ug in 1 SYRINGE, GLASS · 72374-101-01
- 10 SYRINGE, GLASS in 1 CARTON (72374-101-10) / 300 ug in 1 SYRINGE, GLASS · 72374-101-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →